-
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is AssessedMiller WL. -
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyKusumoto FM, Schoenfeld MH, Barrett C et al.
-
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart FailureDB Mark, PA Cowper, KJ Anstrom et al.
-
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF TrialMN Kosiborod, PJhund, KF Docherty et al.
-
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectoriesTF Lüscher
-
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trialMorrow DA, Velazquez EJ, DeVore AD et al.
-
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight CommitteeHollenberg SM, Warner Stevenson L, Ahmad T
-
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative reviewBurlacu A, Simion P, Nistor I et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
